Clinical Trials · NCT03071172
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Enrollment
- 252
- Start date
- Mar 2017
- Locations
- 7 sites, China
- Primary endpoint
- The total number of oocytes obtained during the start-up period